Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FDA rejects Summit’s PD-1xVEGF ivonescimab in NSCLC
Ivonescimab’s setback has narrowed its potential first-mover advantage as several pharma giants race to advance their own PD-(L)1xVEGF bispecifics.
Angus Liu
Nov 15, 2026 7:50am
AstraZeneca cuts 600 US sales jobs: Bloomberg
Nov 13, 2026 5:45pm
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
AZ's Imfinzi keeps MIBC race against Keytruda hot with FDA nod
Nov 13, 2026 5:40pm
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
The Oral GLP-1 Tracker: Foundayo, Wegovy pill keep climibing
Nov 13, 2026 4:15pm
